 |
|
North American Menopause Society’s Ties to Wyeth Pharmaceuticals The North American Menopause Society (NAMS) describes itself as "the leading nonprofit scientific organization devoted to promoting women's health and quality of life through an understanding of menopause.” Unfortunately, as it advocates for policies that benefit Wyeth Pharmaceuticals, NAMS rarely discloses its numerous financial ties to the pharmaceutical manufacturer. The world’s number one manufacturer of prescription hormone products, Wyeth is waging a campaign to restrict patients’ access to one alternative to its products – compounded, bioidentical hormones. By limiting patients’ hormone treatment options, Wyeth would drive sales of its own, proprietary hormone products. NAMS is one of several organizations that receive money from Wyeth and support this campaign. NAMS lobbies lawmakers, regulators, the media and other healthcare organizations in support of Wyeth campaign. A former president of the Los Angeles chapter of the National Organization for Women even criticized NAMS for conducting and promoting a survey in 2002 designed to deflect attention from the health risks of Wyeth’s products. And it does all this while consistently failing to disclose that it receives money from Wyeth. On November 15, 2006, Dr. Wulf Utian, executive director of NAMS, appeared on CNN’s Larry King Live to defend Wyeth’s position. Concerning his relationship with Wyeth, Dr. Utian stated: “I am not funded by Wyeth Pharmaceuticals. I'm not.” His declaration is patently false. Evidence of Dr. Utian’s and NAMS’s financial ties to Wyeth is readily available on the Internet. Some examples follow. NAMS receives unrestricted educational grants from Wyeth, which are used to fund awards, including:
Wyeth has supported many of NAMS’s initiatives and programs.
NAMS’s leadership is closely associated with Wyeth Pharmaceuticals.
For more information on Wyeth's ties to other advocacy organizations, please click here For more information on Wyeth's previous campaigns against alternatives to their products, please click here  North American Menopause Society and Others' Financial Ties to Wyeth Pharmaceuticals › AACE Financial Ties to Wyeth › AAEP and its Leadership Must Disclose Financial Relationships with Veterinary Drug Makers › The Truth Behind Wyeth’s Campaign Against BHRT Patients › Irresponsible Journalism: BusinessWeek Regurgitates Wyeth’s Attacks on Pharmacy Compounding › Wyeth’s Campaign to Protect Market Share at the Expense of Women’s Health › Wyeth's Previous Campaign to Stifle Generic Alternatives › Pharmacy Compounding Subject to FDA Approval? The Facts Just Don't Fit › Landmark Ruling for Pharmacy Compounding in U.S. District Court › FDA Issues Warning Letters to Pharmacies › Internal FDA Memorandum Contradicts Public Statements › Heard on the Street...Statements in Support of Compounding Pharmacy Practice › How AstraZeneca is Mischaracterizing Pharmacy Compounding › Flaws in AstraZeneca-backed CHASM’s FDA Filing › What’s Wrong with AAEP’s Discriminatory Conference Policy › |
 |
||||||||
 |
||||||||||
| ‹ Home | © 2010 Compounding Facts |